Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Interest & Investment Income: 2010-2016

Historic Interest & Investment Income for Heron Therapeutics (HRTX) over the last 3 years, with Dec 2016 value amounting to $1.1 million.

  • Heron Therapeutics' Interest & Investment Income was N/A to $1.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $445,000, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is 5.53% up from last year.
  • According to the latest figures from Q4 2016, Heron Therapeutics' Interest & Investment Income is $1.1 million, which was up 606.70% from -$209,000 recorded in Q3 2013.
  • In the past 5 years, Heron Therapeutics' Interest & Investment Income ranged from a high of $1.1 million in Q4 2016 and a low of -$209,000 during Q3 2013.
  • Moreover, its 1-year median value for Interest & Investment Income was $1.1 million (2016), whereas its average is $1.1 million.
  • Over the last 5 years, Heron Therapeutics' Interest & Investment Income had its largest YoY gain of 44.49% in 2012, and its largest YoY loss of 6,000.00% in 2012.
  • Quarterly analysis of 3 years shows Heron Therapeutics' Interest & Investment Income stood at -$197,000 in 2012, then declined by 7.18% to -$209,000 in 2013, then reached $1.1 million in 2016.
  • Its Interest & Investment Income stands at $1.1 million for Q4 2016, versus -$209,000 for Q3 2013 and -$204,000 for Q2 2013.